PDF(Pubmed)
Abstract：
BACKGROUND: Infertility in men causes problems in various aspects of their lives, including personal, family and social life. One of the most important of these problems is anxiety. Anxiety in infertile men can affect their health, quality of life, and response to treatment, highlighting the significance of anxiety in these men. Thus, this systematic review and meta-analysis was conducted to investigate the prevalence of anxiety symptoms in infertile men.
METHODS: To conduct this review study, two researchers independently searched international databases such as PubMed, Cochrane Library, Web of sciences, Scopus, PsyINFO, and the Google scholar search engine in English without considering any time limit until January 2, 2024. Keywords such as \"anxiety,\" \"infertility,\" \"prevalence,\" and \"epidemiology\" were used, taking into account the specific search method of each database. Using the Newcastle-Ottawa Scale (NOS), the quality of the articles was evaluated by two researchers independently.
RESULTS: In the systematic part of the study, 27 studies were included, and given the variety of measurement tools (8 different tools) used to investigate anxiety symptoms in infertile men, 24 studies were analyzed in five subgroups of tools. The pooled prevalence of anxiety symptoms in infertile men was 21.37% (95% CI: 15.73-27.02). The lowest and highest prevalence of anxiety in infertile men were related to the Beck anxiety inventory (BAI) and Depression Anxiety Stress Scales (DASS), accounting for 7.08% (95% CI: 3.27-10.90) and 34.90% (95%CI: 28.90-40.90) values respectively. This prevalence was 19.80% (95%CI: 9.01-30.59) for the Hospital Anxiety and Depression Scale (HADS), 30.06% (95%CI: 18.59-41.52) for the Spielberger Trait Anxiety Inventory (STAI-T), and 18.52% (95%CI: 7.76-29.29) for the Self-Rating Anxiety Scale (SAS).
CONCLUSIONS: The results of this systematic review and meta-analysis indicated that the prevalence of anxiety symptoms in infertile men requires special attention to healthcare planning. The healthcare system of different countries should evaluate the symptoms of anxiety in infertile men and take appropriate measures to reduce them according to the culture of the countries. It is recommended that all infertile couples be assessed for anxiety symptoms using a standardized tool during their initial evaluation.
METHODS: To conduct this review study, two researchers independently searched international databases such as PubMed, Cochrane Library, Web of sciences, Scopus, PsyINFO, and the Google scholar search engine in English without considering any time limit until January 2, 2024. Keywords such as \"anxiety,\" \"infertility,\" \"prevalence,\" and \"epidemiology\" were used, taking into account the specific search method of each database. Using the Newcastle-Ottawa Scale (NOS), the quality of the articles was evaluated by two researchers independently.
RESULTS: In the systematic part of the study, 27 studies were included, and given the variety of measurement tools (8 different tools) used to investigate anxiety symptoms in infertile men, 24 studies were analyzed in five subgroups of tools. The pooled prevalence of anxiety symptoms in infertile men was 21.37% (95% CI: 15.73-27.02). The lowest and highest prevalence of anxiety in infertile men were related to the Beck anxiety inventory (BAI) and Depression Anxiety Stress Scales (DASS), accounting for 7.08% (95% CI: 3.27-10.90) and 34.90% (95%CI: 28.90-40.90) values respectively. This prevalence was 19.80% (95%CI: 9.01-30.59) for the Hospital Anxiety and Depression Scale (HADS), 30.06% (95%CI: 18.59-41.52) for the Spielberger Trait Anxiety Inventory (STAI-T), and 18.52% (95%CI: 7.76-29.29) for the Self-Rating Anxiety Scale (SAS).
CONCLUSIONS: The results of this systematic review and meta-analysis indicated that the prevalence of anxiety symptoms in infertile men requires special attention to healthcare planning. The healthcare system of different countries should evaluate the symptoms of anxiety in infertile men and take appropriate measures to reduce them according to the culture of the countries. It is recommended that all infertile couples be assessed for anxiety symptoms using a standardized tool during their initial evaluation.
摘要：
背景：男性不孕症在他们生活的各个方面引起问题，包括个人,家庭和社会生活。这些问题中最重要的是焦虑。不育男性的焦虑会影响他们的健康，生活质量,以及对治疗的反应，强调焦虑在这些男人身上的重要性。因此，本系统综述和荟萃分析旨在调查不育男性焦虑症状的患病率.
方法：为了进行本综述研究，两名研究人员独立搜索了PubMed等国际数据库，科克伦图书馆,WebofSciences,Scopus,PsyINFO,和谷歌学者搜索引擎的英文不考虑任何时间限制，直到2024年1月2日。关键词如“焦虑，“\”不孕症，“\”患病率，使用了“和”流行病学“，考虑到每个数据库的具体搜索方法。使用纽卡斯尔-渥太华量表(NOS)，文章的质量由两名研究者独立评估.
结果：在研究的系统部分，包括27项研究，考虑到用于调查不育男性焦虑症状的各种测量工具（8种不同的工具），在五个工具亚组中分析了24项研究。不育男性焦虑症状的合并患病率为21.37％（95％CI：15.73-27.02）。不育男性中焦虑的最低和最高患病率与贝克焦虑量表（BAI）和抑郁焦虑应激量表（DASS）有关，分别占7.08%(95%CI:3.27-10.90)和34.90%(95CI:28.90-40.90)值。医院焦虑和抑郁量表（HADS）的患病率为19.80％（95CI：9.01-30.59），斯皮尔伯格特质焦虑量表（STAI-T）的30.06%（95CI：18.59-41.52），焦虑自评量表（SAS）为18.52%（95CI：7.76-29.29）。
结论：本系统评价和荟萃分析的结果表明，不育男性焦虑症状的患病率需要特别关注医疗保健计划。不同国家的医疗系统应评估不育男性的焦虑症状，并根据国家的文化采取适当的措施来减少这些症状。建议在初始评估期间使用标准化工具评估所有不育夫妇的焦虑症状。
方法：为了进行本综述研究，两名研究人员独立搜索了PubMed等国际数据库，科克伦图书馆,WebofSciences,Scopus,PsyINFO,和谷歌学者搜索引擎的英文不考虑任何时间限制，直到2024年1月2日。关键词如“焦虑，“\”不孕症，“\”患病率，使用了“和”流行病学“，考虑到每个数据库的具体搜索方法。使用纽卡斯尔-渥太华量表(NOS)，文章的质量由两名研究者独立评估.
结果：在研究的系统部分，包括27项研究，考虑到用于调查不育男性焦虑症状的各种测量工具（8种不同的工具），在五个工具亚组中分析了24项研究。不育男性焦虑症状的合并患病率为21.37％（95％CI：15.73-27.02）。不育男性中焦虑的最低和最高患病率与贝克焦虑量表（BAI）和抑郁焦虑应激量表（DASS）有关，分别占7.08%(95%CI:3.27-10.90)和34.90%(95CI:28.90-40.90)值。医院焦虑和抑郁量表（HADS）的患病率为19.80％（95CI：9.01-30.59），斯皮尔伯格特质焦虑量表（STAI-T）的30.06%（95CI：18.59-41.52），焦虑自评量表（SAS）为18.52%（95CI：7.76-29.29）。
结论：本系统评价和荟萃分析的结果表明，不育男性焦虑症状的患病率需要特别关注医疗保健计划。不同国家的医疗系统应评估不育男性的焦虑症状，并根据国家的文化采取适当的措施来减少这些症状。建议在初始评估期间使用标准化工具评估所有不育夫妇的焦虑症状。
